Sentinel node SPECT-CT in breast cancer

NuklearMedizin

Volumn 46, Issue 6, 2007, Pages 252-256

  Gallowitsch, Hans Jürgen ^a   Kraschl, P ^b   Igerc, I ^a   Hussein, T ^b   Kresnik, E ^a   Mikosch, P ^a   Kohlfuerst, S ^a   Hausegger, K ^b   Lind, P ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

^b Radiology   (Austria)

Author keywords

Axillary staging; Breast cancer; CT; Sentinel node; SPECT CT

Indexed keywords

NANOCOLL TC 99M;

ARTICLE; AXILLA; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 37349101921     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/nukmed-0101     Document Type: Article

References (21)

1. Alvarez S, Anorbe E, Alcorta P et al. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol 2006 ; 186: 1342-1348.
2. Hata Y, Ogawa Y, Nishioka A et al. Thin section computed tomography in the prone position for detection of axillary lymph node metastases in breast cancer. Oncol Rep 1998; 5: 1403-1406.
3. Hillel PG, van Beek EJ, Taylor C et al. The clinical impact of a combined gamma camera/CT imaging system on somatostatin receptor imaging of neuroendocrine tumours. Clin Radiol 2006; 61: 579-587.
4. Husarik DB, Steinert HC. Single-photon emission computed tomography/computed tomography for sentinel node mapping in breast cancer. Sem Nucl Med 2007; 37: 29-33.
5. Ingui CJ, Shah NP, Oates ME. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Clin Nucl Med 2006 ; 31: 665-672.
6. Lerman H, Lievshitz G, Zak O et al. Improved Sentinel Node Identification by SPECT/CT in Overweight Patients with Breast Cancer. J Nucl Med 2007; 48: 201-206.
7. Lerman H, Metser U, Lievshitz G et al. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging 2006; 33: 329-337.
8. 99mTc-sestamibi scintimammography for assessing axillary lymph node status in breast cancer patients. A prospective study. Eur J Surg Oncol 2006; 32: 933-936.
9. March DE, Wechsler RJ, Kurtz AB et al. CT-pathologic correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr 1991; 15: 440-444.
10. Mathijssen IM, Strijdhorst H, Kiestra SK et al. Added value of ultrasound in screening the clinically negative axilla in breast cancer. J Surg Oncol 2006; 94: 364-367.
11. Mayo JR, Hartman TE, Lee KS et al. CT of the chest: minimal tube current required for good image quality with the least radiation dose. AJR Am J Roentgenol 1995; 164: 603-607.
12. Memarsadeghi M, Riedl CC, Kaneider A et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. Radiology 2006; 241: 367-377.
13. Nori J, Vanzi E, Bazzocchi M et al. Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy. Am J Surg 2007; 193: 16-20.
14. Paajanen H, Kilponen VM, Heikkinen J et al. Feasibility of axillary ultrasound in the quality assessment of sentinel node biopsy in breast cancer surgery. Scand J Surg 2006; 95: 195-198.
15. 99mTc-labelled colloid, based on a multicenter database project. Eur Surg 2002; 34: 272-276.
16. Rudas M, Konstantiniuk P, Horvat R et al. Sentinel lymph node examination: balancing between high workload and low metastasis detection rate. Eur Surg 2002; 34: 277-279.
17. Rufini V, Calcagni ML, Baum RP. Imaging of neuroendocrine tumors. Sem Nucl Med 2006; 36: 228-247.
18. Seenu V, Pa van Kumar MN et al. Potential of magnetic resonance spectroscopy to detect metastasis in axillary lymph nodes in breast cancer. Magn Reson Imaging 2005; 23: 1005-1010.
19. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging for axillary lymph node staging-initial findings. Eur Radiol 2006; 16: 2153-2160.
20. Van Diest PJ, Peterse HL, Borgstein PJ et al. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 1999 ; 26 (Suppl): S43-S49.
21. Yuen S, Yamada K, Goto M et al. CT-based evaluation of axillary sentinel lymph node status in breast cancer: value of added contrast-enhanced study. Acta Radiol 2004; 45: 730-737.